The effects of low density lipoproteins modified by incubation with chondroitin 6-sulfate on human aortic smooth muscle cells

Atherosclerosis

Volumn 147, Issue 1, 1999, Pages 155-166

  Tîrziu, Daniela ^a   Jinga, Victor V ^a   Şerban, Geo ^a   Simionescu, Maya ^a  

^a INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

Author keywords

Atherosclerosis; Chondroitin 6 sulfate; LDL; Mild oxidation; Smooth muscle cells

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; APOLIPOPROTEIN B100; CHONDROITIN 6 SULFATE; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOMER; SCAVENGER RECEPTOR; THYMIDINE;

AORTA MEDIA; ARTICLE; ATHEROSCLEROSIS; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ELECTRON MICROSCOPY; FETUS; HUMAN; HUMAN CELL; INTIMA; MITOGENESIS; OXIDATION; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

AORTA; CELL DIVISION; CELL LINE; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; CHONDROITIN SULFATES; HUMANS; LIPOPROTEINS, LDL; MUSCLE, SMOOTH, VASCULAR; THYMIDINE;

EID: 0345425679     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00187-2     Document Type: Article

References (64)

1. Simionescu N., Vasile E., Lupu F., Popescu G., Simionescu M. Prelesional events in atherogenesis-accumulation of extracellular liposomes in the arterial intima and cardiac valves of the hyperlipidemic rabbit. Am. J. Pathol. 123:1986;109-125.
2. Kruth H.S. Localization of unesterified cholesterol in human atherosclerotic lesions: demonstration of filipine-positive, oil red O-negative particles. Am. J. Pathol. 114:1984;201-208.
3. Masuda J., Ross R. Atherogenesis during low level hypercholesterolemia in the nonhuman primate I fatty streak formation. Arteriosclerosis. 10:1990;164-177.
4. Simionescu M, Simionescu N. Modulation and dysfunctions in the artery intima at the inception of hypercholesterolaemic atherogenesis. In: Born GVR, Schwartz CJ, editors. New Horizons in Coronary Heart Disease. London: Current Science, 1993:11.1-14.
5. Simionescu N, Sima A, Dobrian A, Tirziu D, Simionescu M. Pathobiochemical changes of the arterial wall at the inception of atherosclerosis. In: Vollmer E, Roessner E, editors. Current Topics in Pathology. Berlin, Heidelberg: Springer-Verlag, 1993:1-45.
6. Tirziu D., Dobrian A., Tasca C., Simionescu M., Simionescu N. Intimal thickenings of human aorta contain modified reassembled lipoproteins. Atherosclerosis. 112:1995;101-114.
7. Mora R., Lupu F., Simionescu N. Cytochemical localization of β-lipoproteins and their components in successive stages of hyperlipidemic atherogenesis of rabbit aorta. Atherosclerosis. 79:1989;183-195.
8. Simionescu N., Mora R., Vasile E., Lupu F., Filip D.A., Simionescu M. Prelesional modifications of vessel wall in the hyperlipidemic atherogenesis-extracellular accumulation of modified and reassembled lipoproteins. Ann. N.Y. Acad. Sci. 598:1990;1-16.
9. Guyton J.R., Klemp K.F., Mims M.P. Altered ultra-structure of self-aggregated low density lipoproteins; coalescence of lipid domain forming droplets and vesicles. J. Lipid Res. 32:1991;953-962.
10. Dobrian A., Mora R., Simionescu M., Simionescu N. In vitro formation of oxidatively-modified and reassembled human low-density lipoproteins: antioxidant effect of albumin. Biochim. Biophys. Acta. 1169:1993;12-24.
11. Bhakdi S., Dorweiler B., Kirchmann R., Torzewski J., Weise E., Tranum-Jensen J., Walev I., Wieland E. On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety. J. Exp. Med. 182:1995;1959-1971.
12. Pentikainen M.O., Lehtonen E.M.P., Kovanen P.T. Aggregation and fusion of modified low density lipoprotein. J. Lipid Res. 37:1996;2638-2649.
13. Nievelstein P.F.E.M., Fogelman A.M., Mottino G., Frank J.S. Lipid accumulation in rabbit aortic intima 2 hours after bolus infusion of low density lipoprotein A deep-etch and immunolocalization study of ultrarapidly frozen tissue. Arterioscler. Thromb. 11:1991;1795-1805.
14. Nievelstein-Post P., Mottino G., Fogelman A.M., Frank J. An ultrastructural study of lipoprotein accumulation in cardiac valves of the rabbit. Arterioscler. Thromb. 14:1994;1151-1161.
15. Volker W., Schmidt A., Oortmann W., Broszey T., Faber V., Buddecke E. Mapping of proteoglycans in atherosclerotic lesions. Eur. Heart J. 11:1990;29-40.
16. Camejo G., Olofsson S., Lopez F., Carlsson P., Bondjers G. Identification of apoB-100 segments mediating the interaction of low density lipoproteins with arterial proteoglycans. Arteriosclerosis. 8:1988;368-377.
17. Olsson U., Camejo G., Olofsson S., Bondjers G. Molecular parameters that control the association of low density lipoprotein apoB-100 with chondroitin sulphate. Biochim. Biophys. Acta. 1097:1991;37-44.
18. Hurt E., Bondjers G., Camejo G. Interaction of LDL with human arterial proteoglycans stimulates its uptake by human monocyte-derived macrophages. J. Lipid Res. 31:1990;443-454.
19. Camejo G., Hurt E., Wiklund O., Rosengren B., Lopez F., Bondjers G. Modifications of low-density lipoprotein induced by arterial proteoglycans and chondroitin-6-sulfate. Biochim. Biophys. Acta. 1096:1991;253-261.
20. Cardoso L.E.M., Mourao P.A.S. Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL. Arterioscler. Thromb. 1:1994;115-124.
21. Williams K.J., Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15:1995;551-561.
22. Hurt-Camejo E., Olsson U., Wiklund O., Bondjers G., Camejo G. Cellular consequences of the association of ApoB lipoproteins with proteoglycans. Potential contribution to atherogenesis. Arterioscler. Thromb. Vasc. Biol. 17:1997;1011-1017.
23. Stary H.C. The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life. Eur. Heart. J. 11:1990;3-19.
24. Stary H.C., Chandler A.B., Glagov S. et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. Circulation. 89:1994;2462-2478.
25. Redgrave T.D., Roberts D.C.K., West C.E. Separation of plasma lipoproteins by density gradient ultracentrifugation. Anal. Biochem. 65:1975;42-49.
26. Forte T.M., Nordhausen R.W. Electron microscopy of negatively stained lipoproteins. Methods Enzymol. 128:1971;442-457.
27. Peterson G.L. A simplification of the protein assay method of Lowry et al., which is more generally applicable. Anal. Biochem. 83:1977;346-356.
28. Maizel V.J. Polyacrylamide gel electrophoresis of viral proteins. Methods Virol. 5:1971;179-246.
29. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:1959;911-917.
30. Skipski V.P., Manning J.A. Chromatography of lipids. Enzymology. 1:1968;530-598.
31. Fogelman A.M., Schechter I., Seager J., Hokom M., Child J.S., Edwards P.A. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocytes-macrophages. Proc. Natl. Acad. Sci. USA. 77:1980;2214-2218.
32. Brunk C., Jones K., James T.W. Assay for nanogram quantities of DNA in cellular homogenates. Anal. Biochem. 92:1979;497-500.
33. Naito M., Hayashi T., Kuzuya M., Funaki C., Asai K., Kuzuya F. Fibrinogen is chemotactic for vascular smooth muscle cells. FEBS Lett. 247:1989;358-360.
34. Pittman R.C., Careeo T.C., Glass C.K., Green R.S., Taylor C.A., Attie A.D. A radioiodinated, intracellularly trapped ligand for determination of the sites of plasma protein degradation in vivo. Biochem. J. 212:1983;791-800.
35. Basu S.K., Goldstein J.L., Anderson R.W.G., Brown M.S. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholoesterolemia fibroblasts. Proc. Natl. Acad. Sci. USA. 73:1976;3178-3182.
36. Greenspan P., Mayer E.P., Fowler S.D. Nile red: a selective fluorescent stain for intracellular lipid droplets. J. Cell. Biol. 100:1985;965-973.
37. Fowler S.D., Greenspan P. Application of Nile Red, a fluorescent hydrophobic probe, for the detection of neutral lipid deposits in tissue sections: comparation with Oil Red O. J. Histochem. Cytochem. 33:1985;833-836.
38. Simionescu N., Simionescu M. Galloylglucoses of low molecular weight as mordant in electron microscopy. I: procedure and evidence for mordanting effect. J. Cell. Biol. 70:1976;608-621.
39. Guyton J.R., Keith F.K. Ultrastructural discrimination of lipid droplets and vesicles in atherosclerosis: value of osmium, thiocarbohydrazide-osmium and tannic acid-paraphenylen-diamine technique. J. Histochem. Cytochem. 36:1988;1319-1328.
40. Hoover R.L., Rosenberg R., Haering W., Karnovsky M.J. Inhibition of rat arterial smooth muscle cell proliferation by heparin. II: In vitro studies. Circ. Res. 47:1980;578-583.
41. Camejo G., Hurt E., Romano M. Properties of lipoprotein complexes isolated by affinity chromatography from human aorta. Biomed. Biophys. Acta. 44:1985;389-401.
42. Yla-Herttuala S., Palinski W., Rosenfeld M.E., Parthasarathy S., Carew T.E., Witztum J.L., Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84:1989;1086-1095.
43. Steinbrecher U.P., Lougheed M. Scavenger receptor-independent stimulation of cholesterol esterification in macrophages by low density lipoprotein extracted from human aortic intima. Arterioscler. Thromb. 12:1992;608-625.
44. Camejo G., Hurt-Camejo E., Rosengren B., Wiklund O., Lopez F., Bondjers G. Modification of copper-catalyzed oxidation of low density lipoprotein by proteoglycans and glycosaminoglycans. J. Lipid Res. 32:1991;1983-1991.
45. Hurt-Camejo E., Camejo G., Rosengren B., Lopez F., Ahlstrom C., Fager G., Bondjers G. Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells. Arterioscler. Thromb. 12:1992;569-583.
46. Srinivasan S.R., Dolan P., Radhakrishnamurthy B., Pargaonkar P.S., Berenson G.S. Lipoprotein mucopolysaccharides complexes from human atherosclerotic lesions. Biochim. Biophys. Acta. 388:1975;58-70.
47. Hollander W. Unified concept on the role of acidic mucopolysaccharides and connective tissue proteins in the accumulation of lipids lipoproteins and calcium in the atherosclerotic plaque. Exp. Mol. Pathol. 25:1976;106-120.
48. Camejo G. The interaction of lipids and lipoproteins with the intercellular matrix of arterial tissue: Its possible role in atherogenesis. Adv. Lipid Res. 19:1982;1-54.
49. Wight TN. The vascular extracellular matrix. In: Fuster V, Ross R, Topol E, editors. Atherosclerosis and Coronary Artery Disease. Philadelphia: Lippincott-Raven Publishers, 1996:421-440.
50. Camejo G., Hurt-Camejo E., Wiklund O., Bondjers G. Association of lipoproteins with arterial proteoglycans: Pathological significance. Atherosclerosis. 139:1998;205-222.
51. Auge N., Pieraggi M.T., Thiers J.C., Negre-Salvayre A., Salvayre R. Proliferative and cytotoxic effects of mildly oxidized low-density lipoproteins on vascular smooth-muscle cells. Biochem. J. 309:1995;1015-1020.
52. Chatterjee S. Role of oxidized low density lipoproteins in atherosclerosis. Effects on smooth muscle cell proliferation. Mol. Cell. Biochem. 111:1992;143-147.
53. Guyton J.R., Lenz M.L., Mathews B., Hughes H., Karsan D., Selinger E., Smith C.V. Toxicity of oxidized low density lipoproteins for vascular smooth muscle cells and partial protection by antioxidants. Atherosclerosis. 118:1995;237-249.
54. Autio I., Jaakkola O., Solakivi T., Nikkari T. Oxidized low-density lipoprotein is chemotactic for arterial smooth muscle cells in culture. FEBS Lett. 277:1990;247-249.
55. Auge N., Andrieu N., Negre-Salvayre A., Thiers J.C., Levade T., Salvayre R. The sphingomyelin-ceramide signalling pathway is involved in oxidized low density lipoprotein-induced cell proliferation. J. Biol. Chem. 271:1996;19251-19255.
56. Chatterjee S., Bhunia A.K., Snowden A., Han H. Oxidized low density lipoproteins stimulate galactosyltransferase activity, ras activation, p44 mitogen activated protein kinase and c-fos expression in aortic smooth muscle cells. Glycobiology. 7:1997;703-710.
57. Wolfbauer G., Glick J.M., Minor L.K., Rothblat G.H. Development of the smooth muscle foam cell: uptake of macrophage lipid inclusions. Proc. Natl. Acad. Sci. USA. 83:1986;7760-7764.
58. Stein O, Stein Y. Smooth muscle cells and atheroma: putative pathways for the formation of smooth muscle derived foam cells. In: Born GVR, Schwartz CJ, editors. New Horizons in Coronary Heart Disease. London: Current Science, 1993:7.1-8.
59. Vijayagopal P., Glancy D.L. Macrophages stimulate cholesteryl ester accumulation in cocultured smooth muscle cells incubated with lipoprotein-proteoglycan complex. Arterioscler. Thromb. Vasc. Biol. 16:1996;1112-1121.
60. Goldstein J.L., Brown M.S. The low density lipoprotein pathway and its relation to atherosclerosis. Ann. Rev. Biochem. 46:1977;897-930.
61. Pitas R.E., Friera A., McGuire J., Dejager S. Further characterization of acetyl LDL (scavenger) receptor expressed by rabbit smooth muscle cells and fibroblasts. Arterioscler. Thromb. 12:1992;1235-1244.
62. Dejager S., Mietus-Snyder M., Pitas R.E. Oxidized low density lipoproteins bind to the scavenger receptor expressed by rabbit smooth muscle cells and macrophages. Arterioscler. Thromb. 13:1993;371-378.
63. Kielian M.C., Cohn Z.A. Intralysosomal accumulation of polyanions. II. Polyanion internalization and its influence on lysosomal pH and membrane fluidity. J. Cell. Biol. 93:1982;875-882.
64. Ofman D., Slim G.C., Watt D.K., Yorke S.C. Free radical induced oxidative depolymerisation of chondroitin sulphate and dermatan sulphate. Carbohydr. Polym. 33:1997;47-56.